<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04917614</url>
  </required_header>
  <id_info>
    <org_study_id>TEAS and ObsQoR-10</org_study_id>
    <nct_id>NCT04917614</nct_id>
  </id_info>
  <brief_title>Effect of Transcutaneous Electrical Acupoint Stimulation on Obstetric Quality of Recovery-10 After Cesarean Section</brief_title>
  <official_title>Effect of Transcutaneous Electrical Acupoint Stimulation on Obstetric Quality of Recovery-10 After Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konya Meram State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konya Meram State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this prospective and randomized trial is to investigate the effect of TEAS&#xD;
      on postoperative recovery using the Obstetric Quality of Recovery-10 questionnaire in&#xD;
      patients undergoing elective cesarean section.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acupoint stimulation is postulated to modulate neurological signal transmission through&#xD;
      afferent nociceptive pathways. Acupoint stimulation has been associated with positive effects&#xD;
      on perioperative symptoms such as nausea, pain, and sleep disturbance. Transcutaneous&#xD;
      electrical acupuncture point stimulation (TEAS) is an acupuncture treatment developed by&#xD;
      combining traditional Chinese acupuncture with transcutaneous electrical nerve stimulation.&#xD;
      TEAS has proven to be effective in postoperative pain and nausea-vomiting by applying a&#xD;
      current of different frequencies, intensities, and waveforms through electrodes adhering to&#xD;
      the skin. Using TEAS may relieve perioperative symptoms without increasing the risk of&#xD;
      drug-related adverse events and alleviate and improve the patient's health condition,&#xD;
      including the postoperative perspective.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 18, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Actual">November 14, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery</measure>
    <time_frame>The first 24 hours postoperatively</time_frame>
    <description>Obstetric Quality of Recovery-10 (ObsQoR-10Â©) Scoring Tool</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Recovery</condition>
  <arm_group>
    <arm_group_label>group teas</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the TEAS group will receive preoperative TEAS for 30 min before the spinal anesthesia at Hegu (LI4), Neiguan (PC6), and Zusanli (St 36) with an electronic acupuncture device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>In the sham group, the patients were connected to the electronic acupuncture, but electronic stimulation was not applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Electrical Acupoint Stimulation</intervention_name>
    <description>Transcutaneous Electrical Acupoint Stimulation</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>group teas</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective cesarean operation&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with neurological or psychological diseases&#xD;
&#xD;
          -  patients with chronic analgesic and antidepressant drug use&#xD;
&#xD;
          -  Patients unable to communicate&#xD;
&#xD;
          -  Patients previously treated with TEAS or acupuncture,&#xD;
&#xD;
          -  Patients with heart failure and have pace-maker,&#xD;
&#xD;
          -  patient with local infection in the TEAS area&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>betul kozanhan, M.D.</last_name>
    <phone>+903322210000</phone>
    <email>betulkozanhan@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Betul Kozanhan</name>
      <address>
        <city>Konya</city>
        <zip>42005</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betul Kozanhan</last_name>
      <email>betulkozanhan@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 2, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2021</study_first_posted>
  <last_update_submitted>November 14, 2021</last_update_submitted>
  <last_update_submitted_qc>November 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konya Meram State Hospital</investigator_affiliation>
    <investigator_full_name>Betul Kozanhan</investigator_full_name>
    <investigator_title>Ass.Prof.</investigator_title>
  </responsible_party>
  <keyword>ObsQoR-10T</keyword>
  <keyword>recovery</keyword>
  <keyword>ceserean</keyword>
  <keyword>postoperative</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

